US OptionsDetailed Quotes
IBRX250117C4000
- 0.03
- 0.000.00%
15min DelayClose Jan 17 16:00 ET
0.00High0.00Low
0.00Open0.03Pre Close0 Volume3.33K Open Interest4.00Strike Price0.00Turnover0.00%IV25.16%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma107.33Leverage Ratio--Theta--Rho--Eff Leverage--Vega
ImmunityBio Stock Discussion
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t appreciate my watchlist, STAY ...
Immunitybio: Preparing to Submit Sbla in 2025 for Nmibc Bcg Unresponsive Papillary Disease
ImmunityBio Provides Regulatory Update on Global Submission for ANKTIVA + BCG in BCG Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ in Europe and United Kingdom
Wednesday, 15th January at 5:20 pm
Marketing authorization application for BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with Carcinoma in situ (CIS) submitted to European Medicines Agency (EMA) in December 2024 and anticipated acceptance of application in 2025
Marketing a...
No comment yet